Avelumab in First-line NSCLC (JAVELIN Lung 100)

计划入组 1,214 人 · 首次发布于 2015 年 10 月 15 日

Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs

计划入组 757 人 · 首次发布于 2006 年 4 月 5 日

Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)

计划入组 371 人 · 首次发布于 2015 年 12 月 9 日

Avidin

WEEV prophylactic vaccine (Paladin)

Javelin(Mojave Therapeutics, Inc.)

JAVELIN MEDICAL LTD

Israel

Paladin Labs, Inc.

Canada

FDA Approves JAVADIN Oral Solution for Hypertension, Addressing Swallowing Difficulties in Patient Care

Shockwave Medical's Javelin IVL Catheter Demonstrates Promising Results in PAD Treatment

Knight Therapeutics to Acquire Paladin in $120 Million Strategic Pharmaceutical Deal